Formulary Watch |

Fees and formularies move to center of Medicare Rx benefit debate

Flush from victory in passing patients' rights legislation, Senate Democrats are expected to push for a Medicare prescription drug benefit this fall. The new Senate leadership seems to have found that championing health care is a winning strategy and is eager to build on its success.

Pipeline Preview

Pipeline Preview for August

New chemotherapies for metastatic colorectal cancer may be more effective, but at great cost

New chemotherapeutic agents for metastatic colorectal cancer offer improved survival time, however, at substantial cost, according to a recent economic analysis.